A Randomized, Double-Blind, Active-Controlled Phase 2 Trial to Evaluate a Novel Selective and Reversible Intravenous and Oral P2Y12 Inhibitor Elinogrel Versus Clopidogrel in Patients Undergoing Nonurgent Percutaneous Coronary Intervention: The INNOVATE-PCI Trial
暂无分享,去创建一个
Deepak L. Bhatt | Sunil V. Rao | K. Huber | R. Harrington | R. Welsh | C. Gibson | D. Angiolillo | M. Madan | P. Gurbel | S. Leonardi | W. French | U. Zeymer | J. Kochman | L. Berdan | M. McClure | D. Gretler | V. Thompson | Gayle Paynter | Vivian P. Thompson | S. Rao | Matthew W McClure | C. Gibson
[1] R. Califf,et al. Timing of and risk factors for myocardial ischemic events after percutaneous coronary intervention (IMPACT-II). Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis. , 2000, The American journal of cardiology.
[2] P. Conley,et al. Thienopyridines, but Not Elinogrel, Result in Off-Target Effects at the Vessel Wall That Contribute to Bleeding , 2011, Journal of Pharmacology and Experimental Therapeutics.
[3] E. Antman,et al. Clopidogrel resistance: a new chapter in a fast-moving story. , 2004, Circulation.
[4] Deepak L. Bhatt,et al. Intravenous platelet blockade with cangrelor during PCI. , 2009, The New England journal of medicine.
[5] Deepak L. Bhatt,et al. Rationale and design of the randomized, double-blind trial testing INtraveNous and Oral administration of elinogrel, a selective and reversible P2Y(12)-receptor inhibitor, versus clopidogrel to eVAluate Tolerability and Efficacy in nonurgent Percutaneous Coronary Interventions patients (INNOVATE-PCI , 2010, American heart journal.
[6] G. Montalescot,et al. Can we override clopidogrel resistance? , 2009, Circulation.
[7] M. Gurney,et al. Limitations of current therapies to prevent thrombosis: a need for novel strategies. , 2010, Molecular bioSystems.
[8] Sunil V. Rao,et al. Elinogrel: pharmacological principles, preclinical and early phase clinical testing. , 2010, Future Cardiology.
[9] P. Gurbel,et al. Onset and extent of platelet inhibition by clopidogrel loading in patients undergoing elective coronary stenting: the Plavix Reduction Of New Thrombus Occurrence (PRONTO) trial. , 2003, American heart journal.
[10] J. Ornato,et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patie , 2007, Journal of the American College of Cardiology.
[11] E. Antman,et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. , 2007, The New England journal of medicine.
[12] H. O. Lancaster,et al. Significance Tests in Discrete Distributions , 1961 .
[13] Kevin P. Bliden,et al. Clopidogrel for Coronary Stenting Response Variability, Drug Resistance, and the Effect of Pretreatment Platelet Reactivity , 2003, Circulation.
[14] J. Ornato,et al. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST‐Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update) , 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[15] Jeffrey L. Anderson,et al. 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. , 2008, Journal of the American College of Cardiology.
[16] Christopher E. Buller,et al. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2008, Circulation.
[17] S. King,et al. Commentary for “comparison of drug eluting stents with bare metal stents in unselected patients with acute myocardial infarction” , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[18] S. Werns. Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes , 2011 .
[19] Gregg W Stone,et al. Platelet inhibition with cangrelor in patients undergoing PCI. , 2009, The New England journal of medicine.
[20] Claes Held,et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. , 2009, The New England journal of medicine.
[21] G. Lamas,et al. Focused Update of the ACC / AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction , 2007 .